Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azaron
2. Histantin
3. Pyribenzamine
4. Tripelennamine
5. Tripelennamine Citrate
6. Tripelennamine Citrate (1:1)
7. Tripelennamine Maleate
8. Tripelennamine Maleate (1:1)
9. Tripelennamine Monohydrochloride
10. Vetibenzamin
1. 154-69-8
2. Tripelennamine Hcl
3. Ahistamin
4. Dehistin
5. Piristin
6. Pyrinamine
7. Stanzamine
8. Tripelennamine (hydrochloride)
9. Pyribenzamine Hydrochloride
10. Antiallergicum Medivet
11. Dehistin Monohydrochloride
12. Pyribenzamine Monohydrochloride
13. Tripelennamine Monohydrochloride
14. Vetibenzamina
15. Pbz-sr
16. N1-benzyl-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diamine Hydrochloride
17. Pyribenzamine Hcl
18. 22306-05-4
19. Fwv8gj56zn
20. Nsc-409943
21. 154-69-8 (hcl)
22. Smr000058623
23. Mls000069522
24. Mls001148406
25. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine Monohydrochloride
26. N-benzyl-n',n'-dimethyl-n-2-pyridyl-ethylenediamine Hydrochloride
27. N,n-dimethyl-n'-(2-pyridyl)-n'-benzylethylenediamine Hydrochloride
28. Tripelennamine Hydrochloride [usp]
29. 1,2-ethanediamine, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, Hydrochloride
30. 1,2-ethanediamine, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, Monohydrochloride
31. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine Hydrochloride
32. Recovr
33. N'-benzyl-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine;hydrochloride
34. Tri-tumine
35. Tripelennamine Hydrochloride (usp)
36. N-benzyl-n-[2-(dimethylamino)ethyl]pyridin-2-amine Hydrochloride
37. N,n-dimethyl-n-(phenylmethyl)-n-pyridin-2-ylethane-1,2-diamine Hydrochloride
38. Ccris 1969
39. Re-covr Injectable (veterinary)
40. Sr-01000003013
41. Einecs 205-833-5
42. Unii-fwv8gj56zn
43. Nih 10186
44. Nsc 409943
45. Pyrabenzamine
46. 2-[benzyl[2-(dimethylamino)ethyl]amino]pyridine Hydrochloride
47. Mfcd00012815
48. Tripelennamine Chloride
49. Cpd000058623
50. N-benzyl-n-dimethylaminoethyl Alpha-aminopyridine Hydrochloride
51. Opera_id_1597
52. Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, Hydrochloride
53. Tripelennaminehydrochloride
54. Tripelenamine Hydrochloride
55. Ethylenediamine, N-benzyl-n',n'-dimethyl-n-(2-pyridyl)-, Hydrochloride
56. Tripelannamine Hydrochloride
57. N-benzyl-n-alpha-pyridyl-n',n'-dimethyl-aethylendiamin-hydrochlorid [german]
58. Pbz-sr (tn)
59. N(sup 1)-alpha-pyridyl-n(sup 1)-benzyl-n,n-dimethyl Ethylenediamine Monohydrochloride
60. Schembl98916
61. Mls000758254
62. Mls001423999
63. Chloropyramine Impurity 1 Hcl
64. Chembl1200446
65. Dtxsid6026248
66. Pyristine (pristina) Hydrochloride
67. N-benzyl-n-alpha-pyridyl-n',n'-dimethyl-aethylendiamin-hydrochlorid
68. Nsc409943
69. Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, Monohydrochloride
70. S3146
71. Akos015913800
72. N'-benzyl-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine Hydrochloride
73. Ccg-100816
74. Cs-1395
75. Nc00066
76. 1,2-ethanediamine, N1,n1-dimethyl-n2-(phenylmethyl)-n2-2-pyridinyl-, Hydrochloride (1:?)
77. Tripelennamine Hydrochloride [mi]
78. As-59347
79. Hy-17428
80. Db-043233
81. Tripelennamine Hydrochloride [mart.]
82. Tripelennamine Hydrochloride [vandf]
83. Ft-0631854
84. Sw197446-3
85. Tripelennamine Hydrochloride [usp-rs]
86. Tripelennamine Hydrochloride [who-dd]
87. D02091
88. D70467
89. Wln: T6nj Bn1r & 2n1 & 1 & Gh
90. Tripelennamine Hydrochloride [green Book]
91. Tripelennamine Hydrochloride, Analytical Standard
92. A809564
93. Tripelennamine Hydrochloride [orange Book]
94. Sr-01000003013-6
95. Sr-01000003013-7
96. Tripelennamine Hydrochloride [usp Monograph]
97. W-108029
98. Q27278242
99. Z1552027600
100. Ethylenediamine,n'-dimethyl-n-(2-pyridyl)-, Hydrochloride
101. Tripelennamine Hydrochloride 100 Microg/ml In Acetonitrile
102. 2-(benzyl(2-(dimethylamino)ethyl)amino)-pyridine Hydrochloride
103. 2-(benzyl(2-(dimethylamino)ethyl)amino)-pyridinhydrochloride
104. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridinemonohydrochloride
105. 1, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, Monohydrochloride
106. N-[benzyl-n-(dimethylamino)ethyl] .alpha.-aminopyridine Hydrochloride
107. N-benzyl-n',n'-dimethyl-n-pyridin-2-ylethane-1,2-diamine Hydrochloride
108. N-benzyl-n-.alpha.-pyridyl-n',n'-dimethyl-aethylendiamin-hydrochlorid
109. 1,2-ethanediamine,n1,n1-dimethyl-n2-(phenylmethyl)-n2-2-pyridinyl-,hydrochloride
110. N(sup 1)-.alpha.-pyridyl-n(sup 1)-benzyl-n,n-dimethyl Ethylenediamine Monohydrochloride
111. N~1~-benzyl-n~2~,n~2~-dimethyl-n~1~-(2-pyridinyl)-1,2-ethanediamine Hydrochloride
112. Tripelennamine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
113. N'-benzyl-n,n-dimethyl-n'-(2-pyridyl)ethane-1,2-diamine Hydrochloride;tripelennamine Hydrochloride
Molecular Weight | 291.82 g/mol |
---|---|
Molecular Formula | C16H22ClN3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 291.1502254 g/mol |
Monoisotopic Mass | 291.1502254 g/mol |
Topological Polar Surface Area | 19.4 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 236 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10582
Submission : 1993-11-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10582
Submission : 1993-11-19
Status : Inactive
Type : II
NDC Package Code : 71052-077
Start Marketing Date : 2019-10-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000g/1000g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69018-100
Start Marketing Date : 2001-12-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 90027-012
Start Marketing Date : 2022-05-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?